
Precision Oncology Strategy in Trastuzumab-Resistant Human Epidermal Growth Factor Receptor 2–Positive Colon Cancer: Case Report of Durable Response to Ado-Trastuzumab Emtansine
Author(s) -
Derrick S. Haslem,
Hanlee P. Ji,
James M. Ford,
Lincoln Nadauld
Publication year - 2017
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.16.00055
Subject(s) - trastuzumab , trastuzumab emtansine , human epidermal growth factor receptor 2 , oncology , medicine , colorectal cancer , epidermal growth factor receptor , cancer , metastatic breast cancer , cancer research , breast cancer